Immunological and Molecular Correlates of Disease Recurrence after Liver Resection for Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

Immunological and Molecular Correlates of Disease Recurrence after Liver Resection for Hepatocellular Carcinoma

Published:2012-03-02 Issue:3 Volume:7 Page:e32493
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Cariani Elisabetta,Pilli Massimo,Zerbini Alessandro,Rota Cristina,Olivani Andrea,Pelosi Guido,Schianchi Claudia,Soliani Paolo,Campanini Nicoletta,Silini Enrico Maria,Trenti Tommaso,Ferrari Carlo,Missale Gabriele

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference33 articles.

1. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis.;HB El-Serag;Gastroenterology,2007

2. Molecular prognostication of liver cancer: end of the beginning.;SS Thorgeirsson;J Hepatol,2006

3. Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment.;A Budhu;Cancer Cell,2006

4. Gene expression in fixed tissues and outcome in hepatocellular carcinoma.;Y Hoshida;N Engl J Med,2008

5. Focal gains of VEGFA and molecular classification of hepatocellular carcinoma.;DY Chiang;Cancer Res,2008

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. JDF promotes the apoptosis of M2 macrophages and reduces epithelial-mesenchymal transition and migration of liver cancer cells by inhibiting CSF-1/PI3K/AKT signaling pathway;Heliyon;2024-08

2. Impact of inflammation and the immune system on hepatocellular carcinoma recurrence after hepatectomy;Cancer Medicine;2024-02

3. Decoding Immune Signature to Detect the Risk for Early-Stage HCC Recurrence;Cancers;2023-05-12

4. Phase I study of adjuvant immunotherapy with autologous tumor-infiltrating lymphocytes in locally advanced cervical cancer;Journal of Clinical Investigation;2022-08-01

5. Tertiary Lymphatic Structures in Primary Hepatic Carcinoma: Controversy Cannot Overshadow Hope;Frontiers in Immunology;2022-06-29